Last deal

$26M

Amount

Series C

Stage

07.06.2023

Date

14

all rounds

$177.8M

Total amount

General

About Company
Vertos Medical develops and markets medical devices for the treatment of common spinal diseases.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Vertos, X-Sten

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company offers minimally invasive devices for the treatment of lumbar spinal stenosis (LSS) that require no implants, general anesthesia, or stitches. Its proprietary technology, Mild®, is an image-guided outpatient procedure that removes a major root cause of LSS through a small incision. The Mild Procedure has a safety profile equivalent to epidural steroid injections with durability out to 5 years, and patients typically return to activities of daily living within 24 hours with no restrictions. Vertos Medical is committed to pursuing and hiring a diverse workforce.
Contacts